The 340B drug discount program was created in 1992 to lower outpatient drug costs for healthcare organizations predominantly serving low-income, vulnerable patient populations. The program has continued to grow since then, partly driven by misuse, and has placed significant gross-to-net (GTN) pressure on manufacturers. Check out this fact sheet to learn more about the 340B program’s origin, how it works, and how it has evolved over time.

Click here for a printable PDF